Surrozen (SRZN) EBITDA Margin (2024 - 2026)

Surrozen (SRZN) recorded quarterly EBITDA Margin of 209.12% in Q1 2026, up 91.26% quarter-over-quarter from 2393.75% in Q4 2025, and up 76250.0% on a YoY basis from N/an in Q1 2025.

Surrozen (SRZN) EBITDA Margin (2024 - 2026) Analysis & Trends

Surrozen's EBITDA Margin history runs 3 years deep, the most recent figure standing at 209.12% for Q1 2026.

  • In Q1 2026, EBITDA Margin rose 76250.0% year-over-year to 209.12%; the TTM figure through Mar 2026 stood at 573.75% (down 2138.0% YoY), while the FY2025 annual figure was 1210.58%, down 61402.0% from the prior year.
  • EBITDA Margin was 209.12% for Q1 2026 at Surrozen, up from 2393.75% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 14.34% in Q3 2024 to a low of 4280.76% in Q4 2024.
  • Historically, EBITDA Margin has averaged 1413.46% across 3 years, with a median of 971.62% in 2025.
  • Biggest YoY gain for EBITDA Margin was 188701 bps in 2025; the steepest drop was 109298 bps in 2025.
  • A 3-year view of EBITDA Margin shows it stood at 4280.76% in 2024, then jumped by 44 bps to 2393.75% in 2025, then soared by 91 bps to 209.12% in 2026.
  • The last three EBITDA Margin figures came in at 209.12% (Q1 2026), 2393.75% (Q4 2025), and 1107.32% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 38.10%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Surrozen 225,877.86 -106.68 Mn - -209.12%

Historic Data

Download Data
DateValue
Mar 31, 2026 -209.12%
Dec 31, 2025 -2,393.75%
Sep 30, 2025 -1,107.32%
Jun 30, 2025 -917.29%
Mar 31, 2025 -971.62%
Dec 31, 2024 -4,280.76%
Sep 30, 2024 -14.34%